Clinical trial (CT) disclosure regulatory requirements continue to increase, with mandatory registries and an expanding scope of required disclosure data. This includes the EU Clinical Trial Regulation (CTR)1 as well as the transparency initiatives announced by the EMA2, Health Canada3 and PhRMA4.
As a result, sponsors are under increasing obligations to make CT data available to the public and other researchers that have not traditionally been disclosed on registries (such as ClinicalTrials.gov5 and euclinicaltrials.eu6).
The IQVIA clinical trial disclosure group is dedicated to providing you a single-source solution as you pull together the different required elements, including:
Create transparency in your regulatory documents with a range of medical writing services that deliver quality and timeliness throughout your product development lifecycle.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
.svg){kind=icon}
